5377 - 5388 of 7740 results
0.35 CME CREDIT

In this podcast, Dr. Richard Pratley will answer Pri-Med learner questions submitted during recent CME sessions focusing on glucagon like peptide-1 receptor agonists (GLP-1 RAs). Join us for expert answers to questions about who can benefit from GLP-1 RAs, the safety of these medications in different populations, and much more. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/10/2020 and they are subject to change as new information is published.


0.25 CME CREDIT

GLP-1 Receptor Agonists: A Cardiology Perspective (Podcast)

0.25 CME/MOC
0.25 AANP | 0.25 Pharmacology

In this podcast, cardiologist Ty Gluckman will take a deep dive into the cardiology benefits of glucagon like peptide-1 receptor agonists (GLP-1 RA). He will review the clinical trial data which has resulted in GLP-1 RA incorporation into guidelines, which address patients who have both diabetes and atherosclerotic cardiovascular disease. Dr. Gluckman will bring the perspective of a cardiologist into the discussion of these agents with emerging significance in cardiovascular risk reduction.


Strategies for Effective Pain Management

6.50 CME/MOC
6.83 AANP | 3.14 Pharmacology


0.5 CME CREDIT

Treating chronic pain in older individuals and balancing analgesia and adverse effects in this population, which is often afflicted with multiple comorbidities, is challenging. This program reviews the assessment and nonpharmacologic treatment of chronic pain in patients aged 65 years and older. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).


0.292 CME CREDIT

The vast majority of opioid overdoses are inadvertent. While not a substitute for emergency medical care, naloxone can reduce the risk of opioid overdose mortality. It is important for medical professionals, patients, and families to become familiar with naloxone use.


1.5 CME CREDITS

Strategies for Effective Pain Management: The Basics

1.50 CME/MOC
1.50 AANP | 0.38 Pharmacology

This activity will discuss the epidemiology and pathophysiology of acute and chronic pain, patient assessment, assessment of risk for opioid-related aberrant behaviors, nonpharmacologic approaches to pain management, and non-opioid analgesics. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/19/2020 and they are subject to change as new information is published.


0.35 CME CREDIT

Pain Points: Nonopioid Pharmacologic Options in Older Adults

0.25 CME/MOC
0.35 AANP | 0.23 Pharmacology

Nonopioid therapy is an important tool for the treatment of chronic pain. But agents differ as to efficacy and safety in older patients. This program reviews the different classes of nonopioid medications, their efficacy in different types of pain, and their use in older patients. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).


0.5 CME CREDIT

Jeopardy! Severe Asthma Edition

0.50 CME/MOC
0.50 AANP | 0.25 Pharmacology

Test your knowledge on severe asthma with this interactive game of Jeopardy! Learn about diagnosis, biomarkers and assessment tools, medications and management, asthma heterogeneity, and associated conditions as you try to get a high score! Please note that any data, indications, and guidelines presented in this activity are current as of 7/2/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

Jeopardy! Using GLP-1 RAs in the Clinic

0.50 CME/MOC
0.50 AANP | 0.50 Pharmacology

Step into the clinic and onto the game show floor! In this interactive game of Jeopardy! test your knowledge of GLP-1 RAs in various patient encounters where you can implement your knowledge of type 2 diabetes management algorithms and use shared decision with patients. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 09/30/2020 and they are subject to change as new information is published.


0.275 CME CREDIT

Join neurologist and pain specialist, Dr. Charles Argoff, as he discusses a recent expert consensus on best practices in performing a pain assessment—including appropriate components of the physical exam—via telemedicine. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 2/20/2021 and they are subject to change as new information is published.


0.83 CME CREDIT

Meet your next patient: follow this case of a 23-year-old woman with shortness of breath from presentation to diagnosis, management, and monitoring to improve your care of patients with difficult-to-control asthma. Please note that any data, indications, and guidelines presented in this activity are current as of 6/18/2020 and they are subject to change as new information is published.